[Immunological exploration of cancer patients. II. Tumoral immunity].
D000230:Adenocarcinoma / Q000276:immunology; D001932:Brain Neoplasms / Q000276:immunology; D001943:Breast Neoplasms / Q000276:immunology; D002822:Choriocarcinoma / Q000276:immunology; D003110:Colonic Neoplasms / Q000276:immunology; D005260:Female; D005833:Genital Neoplasms, Female / Q000276:immunology; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007822:Laryngeal Neoplasms / Q000276:immunology; D007938:Leukemia / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D008545:Melanoma / Q000276:immunology; D009365:Neoplasm Regression, Spontaneous; D009369:Neoplasms / Q000276:immunology*; D009447:Neuroblastoma / Q000276:immunology; D010610:Pharyngeal Neoplasms / Q000276:immunology; D011247:Pregnancy; D012509:Sarcoma / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology; D013274:Stomach Neoplasms / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology
L'exploration immunitaire des cancéreux. II. Immunité tumorale.